Trade Summary

4 days ago, Dambkowski Carl, serving as Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 26,400 shares at $132.60 per share, for a total transaction value of $3,500,640.00. Following this transaction, Dambkowski Carl now holds 179,248 shares of APGE.

This sale represents a 12.84% decrease in Dambkowski Carl's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 (accepted Jun 24, 8:01 PM ET), 3 days after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.